A Study of the Efficacy and Safety of BCD-248 in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma (AMMADINA)

Clinical trial NCT07742215 · RECRUITING

Trial details

NCT number: NCT07742215
Sponsor: Biocad
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Myeloma Multiple

Start date: 2026-06-15
Primary completion: 2028-07-01
Enrollment: 390

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.